These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3601700)

  • 1. [Evaluation of auditory function in homozygous beta-thalassemia].
    Stura M; Arigliani R; Molinari AC; Tarantino V
    Pediatr Med Chir; 1986; 8(5):703-5. PubMed ID: 3601700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Audiologic evaluation of patients with thalassemic syndromes treated with desferrioxamine B].
    Gaini RM; Moretti E; Boffa C; Terzoli S; Carnelli V
    Pediatr Med Chir; 1988; 10(5):503-4. PubMed ID: 3241755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desferrioxamine ototoxicity in an adult transfusion-dependent population.
    Chiodo AA; Alberti PW; Sher GD; Francombe WH; Tyler B
    J Otolaryngol; 1997 Apr; 26(2):116-22. PubMed ID: 9106087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditory involvement in thalassemia major.
    De Virgiliis S; Argiolu F; Sanna G; Cornacchia G; Cossu P; Cao A; Mallardi V; Puxeddu P
    Acta Haematol; 1979; 61(4):209-15. PubMed ID: 108901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing loss and desferrioxamine in homozygous beta-thalassemia.
    Albera R; Pia F; Morra B; Lacilla M; Bianco L; Gabutti V; Piga A
    Audiology; 1988; 27(4):207-14. PubMed ID: 3190562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early identification and management of hearing impairment.
    Buttross SL; Gearhart JG; Peck JE
    Am Fam Physician; 1995 May; 51(6):1437-46, 1451-2. PubMed ID: 7732946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of the relationship between Down's syndrome and hearing loss.
    Kattan HA; Jarrar RF; Mahasin ZZ
    Saudi Med J; 2000 Oct; 21(10):931-3. PubMed ID: 11369955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term audiological evaluation of beta-thalassemic patients.
    Kontzoglou G; Koussi A; Economou M; Tsatra I; Perifanis V; Noussios G; Athanassiou-Metaxa M
    Acta Otorhinolaryngol Belg; 2004; 58(2):113-7. PubMed ID: 15515654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensory neural hearing loss in beta-thalassemia major patients treated with deferoxamine.
    Shamsian BS; Aminasnafi A; Moghadassian H; Gachkar L; Arzanian MT; Alavi S; Esfehani H; Garallahi F; Amini R
    Pediatr Hematol Oncol; 2008 Sep; 25(6):502-8. PubMed ID: 18728969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Audiologic results in patients with Moebiüs sequence.
    Griz S; Cabral M; Azevedo G; Ventura L
    Int J Pediatr Otorhinolaryngol; 2007 Sep; 71(9):1457-63. PubMed ID: 17640740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prevalence and evolution of hypoacusis in Cooley's disease].
    Cuda D; De Benedetto M; Leante M; Corvaglia E
    Acta Otorhinolaryngol Ital; 1991; 11(5):471-81. PubMed ID: 1820722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Auditive function disturbances. Diagnostic orientation].
    Dauman R
    Rev Prat; 2002 Oct; 52(16):1843-50. PubMed ID: 12564177
    [No Abstract]   [Full Text] [Related]  

  • 13. Osteogenesis imperfecta clinical features, hearing loss and stapedectomy. Biochemical, osteodensitometric, corneometric and histological aspects in comparison with otosclerosis.
    Pedersen U
    Acta Otolaryngol Suppl; 1985; 415():1-36. PubMed ID: 3859176
    [No Abstract]   [Full Text] [Related]  

  • 14. Hearing assessment in pre-school children with speech delay.
    Psillas G; Psifidis A; Antoniadou-Hitoglou M; Kouloulas A
    Auris Nasus Larynx; 2006 Sep; 33(3):259-63. PubMed ID: 16420975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical accuracy of tuning fork tests.
    Stankiewicz JA; Mowry HJ
    Laryngoscope; 1979 Dec; 89(12):1956-63. PubMed ID: 513917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audiologic and vestibular findings in a sample of human immunodeficiency virus type-1-infected Mexican children under highly active antiretroviral therapy.
    Palacios GC; Montalvo MS; Fraire MI; Leon E; Alvarez MT; Solorzano F
    Int J Pediatr Otorhinolaryngol; 2008 Nov; 72(11):1671-81. PubMed ID: 18814921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurophysiological and neuro-otological study of homozygous beta-thalassemia under long-term desferrioxamine (DFO) treatment.
    Triantafyllou N; Fisfis M; Sideris G; Triantafyllou D; Rombos A; Vrettou H; Mantouvalos V; Politi C; Malliara S; Papageorgiou C
    Acta Neurol Scand; 1991 May; 83(5):306-8. PubMed ID: 1648295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conductive hearing loss: investigation of possible inner ear origin in three cases studies.
    Al Muhaimeed H; El Sayed Y; Rabah A; Al-Essa A
    J Laryngol Otol; 2002 Nov; 116(11):942-5. PubMed ID: 12487675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Audiologic and vestibular assessment in patients with β-thalassemia major receiving long-term transfusion therapy.
    Chao YH; Wu KH; Lin CY; Tsai MH; Peng CT; Wu HP; Lin CD
    Pediatr Blood Cancer; 2013 Dec; 60(12):1963-6. PubMed ID: 23956204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensorineural hearing loss in children with thalassemia major in Northern Greece.
    Kontzoglou G; Koussi A; Tsatra J; Noussios G; Vital V; Sagarakis G; Athanassiou M
    Int J Pediatr Otorhinolaryngol; 1996 May; 35(3):223-30. PubMed ID: 8762595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.